1. Home
  2. SNGX vs BAOS Comparison

SNGX vs BAOS Comparison

Compare SNGX & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.36

Market Cap

5.6M

Sector

Health Care

ML Signal

HOLD

BAOS

Baosheng Media Group Holdings

HOLD

Current Price

$1.93

Market Cap

4.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNGX
BAOS
Founded
1987
2018
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
4.0M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
SNGX
BAOS
Price
$0.36
$1.93
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
539.9K
11.1K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
57.03
N/A
EPS
N/A
N/A
Revenue
$119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$1.80
52 Week High
$6.23
$5.40

Technical Indicators

Market Signals
Indicator
SNGX
BAOS
Relative Strength Index (RSI) 38.03 29.04
Support Level $0.28 N/A
Resistance Level $0.41 $2.98
Average True Range (ATR) 0.02 0.23
MACD 0.01 -0.05
Stochastic Oscillator 17.90 9.41

Price Performance

Historical Comparison
SNGX
BAOS

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd is a China-based online marketing solution provider. The company provides internet marketing, short-video and V-log marketing, content production and operation, e-commerce marketing, data platform services, and AI technology-related services. It also offers customized marketing solutions and channel marketing services through partnerships with internet platforms such as Tencent, Alibaba, ByteDance, and Kuaishou.

Share on Social Networks: